Okay little buddy, this article talks about a big AIish company called Novo Nordisk that makes medicines to help people with diabetes and other health problems. Some rich and smart people who buy and sell lots of these medicines are called "whales" because they have a lot of money and influence in the market. The article wants us to look at what these whales are doing with their money and how many of them are buying or selling Novo Nordisk's medicines. Read from source...

1. The title is misleading and sensationalized, as it implies that the whales are doing something unusual or significant with NVO, while in fact they are just exercising their options.
2. The article does not provide any context or explanation for what a strike price range is, how it relates to options trading, or why it might be important to investors.
3. The article does not mention the expiration date of the options, which is a crucial factor in determining their value and potential profitability.
4. The article does not disclose any sources for the whale activity data, nor does it verify its accuracy or reliability.
5. The article provides no analysis or interpretation of the trade volume and open interest figures, leaving readers to wonder why they might be relevant or meaningful.
6. The article introduces Novo Nordisk's business model and market position without any context or comparison to other competitors in the same industry or sector.
7. The article abruptly shifts from discussing options activity to evaluating the company's performance, without explaining how the two are related or what factors might influence either outcome.
8. The article ends with a vague and unhelpful statement about the current trading volume and price of NVO, without offering any insight into why they are moving in that direction or what implications they might have for investors.

Given the whale activity within a strike price range from $100.0 to $160.0 in the last 30 days, I would suggest the following investment strategies for NVO: